MSH2 and Leigh syndrome: LS is an autosomal dominant cancer syndrome caused by mutations in one of the mismatch repair genes MLH1, MSH2, MSH6, and PMS2. EC shares with colorectal cancer (CRC) an equal role as a sentinel (i.e., first presenting) malignancy, and the lifetime risk of developing EC in LS patients is approximately 40% [6].